Nektar Therapeutics (NKTR)
65.84
+2.19
(+3.44%)
USD |
NASDAQ |
Jun 29, 15:04
Nektar Therapeutics Cash from Investing (TTM) : -395.68M for March 31, 2026
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -395.68M |
| December 31, 2025 | -1.197M |
| September 30, 2025 | 58.64M |
| June 30, 2025 | 199.63M |
| March 31, 2025 | 167.00M |
| December 31, 2024 | 142.57M |
| September 30, 2024 | 99.74M |
| June 30, 2024 | 110.04M |
| March 31, 2024 | 118.22M |
| December 31, 2023 | 139.56M |
| September 30, 2023 | 162.20M |
| June 30, 2023 | 217.18M |
| March 31, 2023 | 276.16M |
| December 31, 2022 | 365.84M |
| September 30, 2022 | 446.02M |
| June 30, 2022 | 333.79M |
| March 31, 2022 | 322.60M |
| December 31, 2021 | 202.78M |
| September 30, 2021 | 175.32M |
| June 30, 2021 | 224.82M |
| March 31, 2021 | 308.90M |
| December 31, 2020 | 496.21M |
| September 30, 2020 | 538.95M |
| June 30, 2020 | 548.54M |
| March 31, 2020 | 416.79M |
| Date | Value |
|---|---|
| December 31, 2019 | 206.89M |
| September 30, 2019 | 158.94M |
| June 30, 2019 | -520.58M |
| March 31, 2019 | -1.440B |
| December 31, 2018 | -1.380B |
| September 30, 2018 | -1.444B |
| June 30, 2018 | -903.92M |
| March 31, 2018 | 32.47M |
| December 31, 2017 | -28.81M |
| September 30, 2017 | -193.89M |
| June 30, 2017 | -84.82M |
| March 31, 2017 | -131.72M |
| December 31, 2016 | -82.40M |
| September 30, 2016 | 52.50M |
| June 30, 2016 | 4.823M |
| March 31, 2016 | -56.25M |
| December 31, 2015 | -39.34M |
| September 30, 2015 | -56.94M |
| June 30, 2015 | 2.504M |
| March 31, 2015 | 73.80M |
| December 31, 2014 | -37.57M |
| September 30, 2014 | -94.91M |
| June 30, 2014 | -93.28M |
| March 31, 2014 | -51.99M |
| December 31, 2013 | 49.91M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Aquestive Therapeutics, Inc. | -0.479M |
| Eli Lilly & Co. | -11.54B |
| Boston Scientific Corp. | -2.731B |
| Tvardi Therapeutics, Inc. | -5.108M |
| Johnson & Johnson | -24.33B |